279 related articles for article (PubMed ID: 29076444)
1. [Faecal microbiota transplantation: indications in perspective].
van Beurden YH; Terveer EM; Keller JJ; Kuijper EJ; Mulder CJJ; Vandenbroucke-Grauls CMJE
Ned Tijdschr Geneeskd; 2017; 161():D1623. PubMed ID: 29076444
[TBL] [Abstract][Full Text] [Related]
2. [Faecal transplantation as a treatment for Clostridium difficile infection, ulcerative colitis and the metabolic syndrome].
Carstensen JW; Hansen AK
Ugeskr Laeger; 2014 Feb; 176(4):. PubMed ID: 25095865
[TBL] [Abstract][Full Text] [Related]
3. Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.
Vermeire S; Joossens M; Verbeke K; Wang J; Machiels K; Sabino J; Ferrante M; Van Assche G; Rutgeerts P; Raes J
J Crohns Colitis; 2016 Apr; 10(4):387-94. PubMed ID: 26519463
[TBL] [Abstract][Full Text] [Related]
4. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
[TBL] [Abstract][Full Text] [Related]
5. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
Kump P; Högenauer C
Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
Allegretti JR; Kelly CR; Grinspan A; Mullish BH; Kassam Z; Fischer M
Gastroenterology; 2020 Nov; 159(5):1982-1984. PubMed ID: 32738249
[No Abstract] [Full Text] [Related]
7. Gastroenterologist perceptions of faecal microbiota transplantation.
Paramsothy S; Walsh AJ; Borody T; Samuel D; van den Bogaerde J; Leong RW; Connor S; Ng W; Mitchell HM; Kaakoush NO; Kamm MA
World J Gastroenterol; 2015 Oct; 21(38):10907-14. PubMed ID: 26478682
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
[TBL] [Abstract][Full Text] [Related]
9. Enterotoxigenic Clostridium perfringens Infection as an Adverse Event After Faecal Microbiota Transplantation in Two Patients With Ulcerative Colitis and Recurrent Clostridium difficile Infection: A Neglected Agent in Donor Screening.
Azimirad M; Yadegar A; Asadzadeh Aghdaei H; Kelly CR
J Crohns Colitis; 2019 Jul; 13(7):960-961. PubMed ID: 30852608
[No Abstract] [Full Text] [Related]
10. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.
Gravito-Soares M; Gravito-Soares E; Portela F; Ferreira M; Sofia C
Rev Esp Enferm Dig; 2017 Jun; 109(6):473-476. PubMed ID: 28506071
[TBL] [Abstract][Full Text] [Related]
12. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.
Kump P; Wurm P; Gröchenig HP; Wenzl H; Petritsch W; Halwachs B; Wagner M; Stadlbauer V; Eherer A; Hoffmann KM; Deutschmann A; Reicht G; Reiter L; Slawitsch P; Gorkiewicz G; Högenauer C
Aliment Pharmacol Ther; 2018 Jan; 47(1):67-77. PubMed ID: 29052237
[TBL] [Abstract][Full Text] [Related]
13. Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.
Sokol H; Galperine T; Kapel N; Bourlioux P; Seksik P; Barbut F; Scanzi J; Chast F; Batista R; Joly F; Joly AC; Collignon A; Guery B; Beaugerie L;
Dig Liver Dis; 2016 Mar; 48(3):242-7. PubMed ID: 26433619
[TBL] [Abstract][Full Text] [Related]
14. Faecal microbiota transplantation-A clinical view.
Mattner J; Schmidt F; Siegmund B
Int J Med Microbiol; 2016 Aug; 306(5):310-315. PubMed ID: 26924753
[TBL] [Abstract][Full Text] [Related]
15. Faecal microbiota transplantation: what's beyond Clostridium difficile infection?
Tamilarasan AG; Krishnananthan T
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):487-494. PubMed ID: 33177380
[TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.
Li YT; Cai HF; Wang ZH; Xu J; Fang JY
Aliment Pharmacol Ther; 2016 Feb; 43(4):445-57. PubMed ID: 26662643
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection.
Quera R; Espinoza R; Estay C; Rivera D
J Crohns Colitis; 2014 Mar; 8(3):252-3. PubMed ID: 24184170
[No Abstract] [Full Text] [Related]
18. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
[TBL] [Abstract][Full Text] [Related]
19. Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study.
Vendrik KEW; Terveer EM; Kuijper EJ; Nooij S; Boeije-Koppenol E; Sanders IMJG; van Lingen E; Verspaget HW; Berssenbrugge EKL; Keller JJ; van Prehn J;
Lancet Infect Dis; 2021 May; 21(5):711-721. PubMed ID: 33275940
[TBL] [Abstract][Full Text] [Related]
20. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.
Fuentes S; Rossen NG; van der Spek MJ; Hartman JH; Huuskonen L; Korpela K; Salojärvi J; Aalvink S; de Vos WM; D'Haens GR; Zoetendal EG; Ponsioen CY
ISME J; 2017 Aug; 11(8):1877-1889. PubMed ID: 28398347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
